Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission
The next pandemic could begin anywhere, at any moment. And the risk of a deadly outbreak is only rising.
But it doesn’t have to be that way.
CEPI 3.0 is our plan to move the world from reactive response to proactive protection
Our CEO, @DrRHatchett, said: "The rVSV platform has demonstrated its value when responding to previous Zaire ebolavirus outbreaks – and this same technology could now be vital in saving lives against Bundibugyo."
CEPI is providing $1.9 million funding to long-standing partner PHV to quickly generate starting research material needed to advance the company’s investigational rVSV-based vaccine into clinical testing.
📣 CEPI has partnered with Public Health Vaccines to rapidly advance early-stage development of a vaccine candidate against the Bundibugyo ebolavirus in response to the ongoing epidemic in the DRC and neighbouring Uganda.
cepi.net/cepi-awards-pu…
🧵👇
Reminder: This urgent Call for Proposals seeking to accelerate early-stage Bundibugyo virus vaccine candidates closes in just three days (12 June).
Apply now at the link below ⬇️
🚨 CEPI has launched an urgent Call for Proposals seeking to accelerate early‑stage vaccine candidates against Bundibugyo virus (BDBV), following the 2026 public health emergency declared by the Africa CDC and WHO.
With cases rising across the Democratic Republic of the Congo
The race is on: a new strategy from @gavi and @CEPIvaccines looks to develop a trial-ready vaccine for the Bundibugyo Ebola virus in a matter of months. 🧵👇
🚨 NEW: CEPI has launched an additional Call for Proposals in response to the current Bundibugyo virus (BDBV) outbreak in the DRC and Uganda to support critical, time-sensitive activities that directly inform and support vaccine R&D decision-making.
Two workstreams are in
New funding from CEPI will help take a promising nanoparticle vaccine platform into early clinical development, with the aim of speeding up how we respond to future outbreaks.
More ⬇️
The key to an effective global health emergency response is collaboration. At @gavi, we are working in lockstep with our partner @CEPIvaccines, with CEPI leading the way on efforts to accelerate the development of safe and effective vaccines and Gavi investing at-risk to ensure
Are you applying to CEPI’s urgent Call for Proposals to accelerate the development of Bundibugyo virus vaccine candidates?
Join our upcoming webinar and live Q&A session.
This session is designed to support prospective applicants by addressing key questions on the scope of the
🚨 CEPI has launched an urgent Call for Proposals seeking to accelerate early‑stage vaccine candidates against Bundibugyo virus (BDBV), following the 2026 public health emergency declared by the Africa CDC and WHO.
With cases rising across the Democratic Republic of the Congo
CEPI's latest newsletter is now available!
From funding to accelerate development of three #Bundibugyo virus vaccine candidates to renewed commitments to support CEPI 3.0, a lot has happened over the last month.
Catch up: